Hasil Pencarian - David A Roth

  • Menampilkan 1 - 11 hasil dari 11
Perbaiki Hasil
  1. 1
    Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE

    Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE oleh William Stohl, Milena Kurtinecz, David A Roth, Herbert Struemper, William W Freimuth, Lisa Edwards

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data

    Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data oleh Anne Hammer, Beulah Ji, David A Roth, David D'Cruz, Paige Meizlik, Gina Eriksson, Yulia Green

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort

    Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort oleh Qinggong Fu, Michelle A Petri, Daniel W Goldman, David A Roth, Selin Cooper Blenkinsopp, Yulia Green, Anuradha Madan, Patricia Juliao

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea

    Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea oleh Damon Bass, Regina Kurrasch, Sang-Cheol Bae, Beulah Ji, David A Roth, Jenny Lowe, Myron Chu, Paula Curtis, Kathleen DeRose, Paige Meizlik

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    EMBRACE: One Small Story in Lupus—One Giant Challenge in Clinical Trials

    EMBRACE: One Small Story in Lupus—One Giant Challenge in Clinical Trials oleh Saira Z. Sheikh, Tessa R. Englund, Susan W. Burriss, Jonca Bull, Anya Harry, James G. Groark, Ashley M. Hall, Michelle Miller, David A. Roth

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    1104 Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) With Relapsed and Newly Diagnosed Active Lupus Nephritis (LN)

    1104 Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) With Relapsed and Newly Diagnosed Active Lupus Nephritis (LN) oleh Brad H Rovin, Hans-Joachim Anders, Ming-hui Zhao, Ana Malvar, David A Roth, Keiju Hiromura, Jennifer Gilbride, Yulia Green, Anuradha Madan, Angela Jones- Leone, Tania Gonzalez-Rivera

    Diterbitkan 2022-12-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study

    The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study oleh Sang-Cheol Bae, Damon L. Bass, Myron Chu, Paula Curtis, Richard Dimelow, Laurence Harvey, Beulah Ji, Regina Kurrasch, Saima Muzaffar, Raj Punwaney, David A. Roth, Yeong-Wook Song, Wendy Xie, Fengchun Zhang

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years

    Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years oleh Damon Bass, Regina Kurrasch, Yin Su, Jie Zheng, Yang Li, Guochun Wang, Fengchun Zhang, David A Roth, Jieruo Gu, Jenny Lowe, Myron Chu, Paula Curtis, Kathleen DeRose, Paige Meizlik, Mingjun Wang, Xingfu Li

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison

    Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison oleh Hermine I Brunner, Nicolino Ruperto, Clarissa A Pilkington, Damon L Bass, Mohamed Okily, Holly Quasny, Fengchun Zhang, Syuji Takei, Carlos Abud-Mendoza, Diego O Viola, Beulah N Ji, David A Roth, Masaaki Mori, Sandra Navarra, Reema Syed, Gina Eriksson, Anne E Hammer

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome

    A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome oleh Xavier Mariette, Francesca Barone, Chiara Baldini, Hendrika Bootsma, Kenneth L. Clark, Salvatore De Vita, David H. Gardner, Robert B. Henderson, Michael Herdman, Karoline Lerang, Prafull Mistry, Raj Punwaney, Raphaele Seror, John Stone, Paul L.A. van Daele, André van Maurik, Nicolas Wisniacki, David A. Roth, Paul Peter Tak

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Bottled water contaminant exposures and potential human effects

    Bottled water contaminant exposures and potential human effects oleh Paul M. Bradley, Kristin M. Romanok, Kelly L. Smalling, Michael J. Focazio, Nicola Evans, Suzanne C. Fitzpatrick, Carrie E. Givens, Stephanie E. Gordon, James L. Gray, Emily M. Green, Dale W. Griffin, Michelle L. Hladik, Leslie K. Kanagy, John T. Lisle, Keith A. Loftin, R. Blaine McCleskey, Elizabeth K. Medlock–Kakaley, Ana Navas-Acien, David A. Roth, Paul South, Christopher P. Weis

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: